We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HLIO:NYSEHelios Technologies, Inc. Analysis

Data as of 2026-05-19 - not real-time

$77.17

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Helios Technologies (HLIO) entered the quarter with a 23% year‑over‑year sales increase, beating analyst revenue forecasts. The company posted an EPS beat of 21%, reinforcing the bullish momentum seen in its price chart. Technical indicators are supportive: the price sits above the 20‑day (≈$70) and 50‑day (≈$68) SMAs, the MACD histogram is positive, and RSI sits at a healthy 64. Volume is on an upward trend, and the stock is trading near its $80 resistance level with a solid $65 support cushion. The Fear & Greed Index reads “Extreme Greed,” reflecting strong market sentiment.
However, the current market price of $77.17 exceeds the DCF‑derived fair value of $68.2 and trades at a trailing P/E of 42 versus an industry average of 29, suggesting the stock is overvalued. The dividend yield of 0.62% is backed by a modest 15% payout ratio and robust free cash flow, indicating sustainability. With a beta of 1.53 and 30‑day volatility above 50%, the equity carries elevated market risk. Nonetheless, its diversified global footprint and low debt‑to‑equity profile provide a buffer against sector downturns. Taken together, the fundamentals support a cautious but positive outlook, with upside potential modestly limited by valuation premiums.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish technical setup with price above key SMAs
  • Upcoming earnings expected to confirm beat
  • Proximity to resistance level limiting near‑term upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue and EPS growth trajectory
  • Sustainable dividend and solid free cash flow
  • Upside potential despite current premium valuation

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Diversified global exposure across industrial sectors
  • Low payout ratio ensuring dividend durability
  • Valuation compression risk offset by stable cash generation

Key Metrics & Analysis

Financial Health

Revenue Growth16.80%
Profit Margin6.97%
P/E Ratio42.4
ROE6.69%
ROA4.37%
Debt/Equity39.33
P/B Ratio2.7
Op. Cash Flow$132.2M
Free Cash Flow$98.5M
Industry P/E29.5

Technical Analysis

TrendBullish
RSI63.8
Support$65.13
Resistance$80.00
MA 20$70.24
MA 50$68.15
MA 200$60.13
MACDBullish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair Value$68.17
Target Price$84.67
Upside/Downside9.71%
GradeOvervalued
TypeGrowth
Dividend Yield0.62%

Risk Assessment

Beta1.53
Volatility54.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.